Instruction for use: Viskaldix

Active substance Clopamide + Pindolol

ATX Code C07CA03 Pindolol in combination with other diuretics

Pharmacotherapeutic group:

Beta-blockers in combination

The nosological classification (ICD-10)

I10 Essential (primary) hypertension

Hypertension, Arterial hypertension, Arterial hypertension crisis course, Essential Hypertension

Primary hypertension, Arterial hypertension, complications of diabetes, hypertension, The sudden increase in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial Hypertension, malignant Hypertension, Hypertonic disease, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, The aggravation of hypertensive disease, Transient hypertension, Isolated systolic hypertension

I15 Secondary hypertension

Arterial hypertension, complications of diabetes, hypertension, The sudden rise in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial hypertension, malignant hypertension, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, hypertensive crisis, The aggravation of hypertensive disease, Transient hypertension, hypertension, Arterial hypertension, Arterial hypertension crisis course, renovascular hypertension, symptomatic hypertension, renal hypertension, Renovascular hypertension, Symptomatic hypertension

Structure and Composition

Tablets 1 tab.

5 mg clopamide

10mg pindolol

Excipients: lactose monohydrate; corn starch; magnesium stearate

in blister 10 pcs .; In the paper cartons 2 blisters.

pharmachologic effect

diuretic, hypotensive.

Dosing and Administration

Inside.

The dose should be titrated for each patient individually.

The recommended initial dose - 1 tab. morning. The daily dose can be increased to 2, and if necessary to Table 3. per day, if after 1-2 weeks of administration of the drug is not a satisfactory antihypertensive effect is reached.

In the case of withdrawal of the drug, the dose should be reduced gradually.

Elderly patients. Adjusting the dosing regimen is not required.

Children. Data on the use of Viskaldiks® drug in children under 18 years there.

Violation of the liver and kidneys. When mild to moderate hepatic dysfunction and / or kidney dose adjustment is required. The drug is contraindicated in patients with severe hepatic and / or renal failure.

Conditions of supply of pharmacies

On prescription.

Storage condition

In the dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf-life

5 years.

Do not use beyond the expiration date printed on the package.